Navigation Links
Nepstar Chain Drugstore (NPD) Greenshoe Fully Exercised
Date:11/15/2007

SHENZHEN, China, Nov. 15 /Xinhua-PRNewswire-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, announced today that the underwriters of the Company's initial public offering ("IPO") have exercised their greenshoe option in full to purchase 3,093,750 American Depositary Shares ("ADSs") from the Company at the IPO price of US$16.20 per ADS less the underwriting discount. The option was granted in connection with the Company's IPO, which was priced on November 8, 2007.

Including proceeds from the exercise of the greenshoe option, gross proceeds from the Company's IPO would increase to approximately US$384.2million.

Jiannong Qian, Nepstar's Chief Executive Officer, said: "We are delighted that investors have received our ADSs warmly. The funds raised from our IPO will enable us to further expand our store network and take other measures to reinforce our leading position in China's retail drugstore industry."

Goldman Sachs (Asia) L.L.C. was the sole global coordinator of the offering. Goldman Sachs (Asia) L.L.C. and Merrill Lynch, Pierce, Fenner & Smith Incorporated were the joint bookrunners. CLSA Limited was a co-manager of the offering.

Nepstar's registration statement relating to these securities has been declared effective by the United States Securities and Exchange Commission. This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering of the securities is made only by means of a prospectus forming a part of the effective registration statement. A copy of the prospectus relating to the offering may be obtained by contacting Goldman Sachs & Co. by mail, Attn: Prospectus Department, 85 Broad Street, New York, NY 10004, facsimile: +1-212-902-9316, email: prospectus-ny@ny.email.gs.com.

For more information, please contact:

In Shenzhen:

Lucia Qian

China Nepstar Drugstore Chain Ltd

Tel: +86-755-2641-4065

Email: qianrt@nepstar.cn

In New York:

Ivette Almeida

The Global Consulting Group

Tel: +1-646-284-9455

Email: ialmeida@hfgcg.com

In Hong Kong:

Bruce Shu

Citigate Dewe Rogerson

Tel: +852-2533-4607

Email: bruce.shu@citigate.com.hk


'/>"/>
SOURCE China Nepstar Chain Drugstore Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. China Nepstar Chain Drugstore (NPD) Begins Trading on NYSE
2. With the Largest-Ever Buyout of a National Nursing Home Chain Pending ... New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes
3. NutritionPedia Adds Nutrition Facts for Over 6,000 Menu Items From 70 Leading Fast-Casual and Family Dining Restaurant Chains
4. IntegriChain Enlists Ed Casey and Associates to Drive Counterfeit and Diversion Monitoring Service
5. SEIU Launches Multi-State Grassroots Campaign Calling on the Carlyle Group to Put Care Above Profits in Buyout of Nations Largest Nursing Home Chain
6. Demonstration at Carlyle Group Offices Monday as Grassroots Caravan of Caregivers, Senior Advocates Arrives in D.C. to Speak Out for Improved Care, Staffing at Nations Largest Nursing Home Chain
7. DoD and VA to Reduce Healthcare Supply Chain Costs
8. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
9. PCMA Statement on the Independent Drugstore Lobby Agenda
10. drugstore.com and Revolution Health Group Announce Breakthrough Deal
11. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Worth, TX (PRWEB) , ... October 13, 2017 ... ... financial planning agency serving communities in the greater Dallas, Miami, and Raleigh regions, ... young boy fighting to overcome a rare and deadly chromosome abnormality. , After ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor ... on sciatica in a new episode of "Success Files," which is an award-winning ... innovation and investigates each subject in-depth with passion and integrity. , Sciatica occurs ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: